Tamara Darsow

Tamara Darsow is a Corporate Vice President at Novo Nordisk, where they are responsible for Research and Development Strategy and Portfolio Management. Tamara has been with the company since March 2021.

Prior to their current role, Tamara served as the Corporate Vice President of Research and Early Development Strategy and Portfolio at Novo Nordisk from March 2019 to March 2021. In this role, they were responsible for defining and executing strategies for building a more diverse and scientifically leading pipeline at Novo Nordisk.

From March 2018 to March 2019, Tamara served as the Vice President of R&D Strategy at Novo Nordisk. In this role, they were responsible for developing and executing the company's R&D strategy.

Tamara began their career at the American Diabetes Association, where they served as the Vice President of Research Programs from January 2011 to February 2017. In this role, they oversaw the association's research programs and was responsible for developing and implementing strategy, setting priorities, and managing budgets.

Tamara Darsow completed their Bachelor of Science in Medical Microbiology and Bacteriology at Montana State University-Bozeman. Tamara then went on to complete their Doctor of Philosophy in Molecular and Cellular Biology at University of California, San Diego.

Some of their coworkers include Karin Conde-Knape - Senior Vice President, Global Drug Discovery, Jesper Bøving - Senior Vice President CMC, and Anette Spahn Klausen - EVP Communication Partner. Tamara Darsow reports to Marcus Schindler, EVP for Research and Early Development & Chief Scientific Officer.